SEARCH

SEARCH BY CITATION

References

  • 1
    Sun Q-H, DeLisser HM, Zukowski MM, Paddock C, Albelda SM, Newman PJ. Individually distinct Ig homology domains in PECAM-1 regulate homophilic binding and modulate receptor affinity. J Biol Chem 1996; 271: 110908.
  • 2
    Sun J, Williams J, Yan H-C, Amin KM, Albelda SM, DeLisser HM. Platelet endothelial cell adhesion molecule-1 (PECAM-1) homophilic adhesion is mediated by immunoglobulin-like domains 1 and 2 and depends on the cytoplasmic domain and the level of surface expression. J Biol Chem 1996; 271: 1856170.
  • 3
    Newton JP, Buckley CD, Jones EY, Simmons DL. Residues on both faces of the first immunoglobulin fold contribute to homophilic binding sites on PECAM-1/CD31. J Biol Chem 1997; 272: 2055563.
  • 4
    Ohto H, Maeda H, Shibata Y, Chen RF, Ozaki Y, Higashihara M, Takeuchi A, Tohyama H. A novel leukocyte differentiation antigen: two monoclonal antibodies, TM2 and TM3, define 120-kDa molecule present on neutrophils, monocytes, platelets and activated lymphoblasts. Blood 1985; 66: 87381.
  • 5
    Newman PJ, Berndt MJ, Gorski J, White GC II, Lyman S, Paddock C, Muller WA. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 1990; 247: 121922.
  • 6
    Cicmil M, Thomas JM, Sage T, Barry FA, Leduc M, Bon C, Gibbins JM. Collagen, convulxin and thrombin stimulate aggregation-independent tyrosine phosphorylation of CD31 in platelets. Evidence for the involvement of Src family kinases. J Biol Chem 2000; 275: 2733947.
  • 7
    Cicmil M, Thomas JM, Leduc M, Bon C, Gibbins JM. Platelet endothelial cell adhesion molecule-1 signalling inhibits the activation of human platelets. Blood 2002; 99: 13744.
  • 8
    Patil S, Newman DK, Newman PJ. Platelet endothelial cell adhesion molecule-1 serves as an inhibitory receptor that modulates platelet responses to collagen. Blood 2001; 97: 172732.
  • 9
    Falati S, Patil S, Gross PL, Stapleton M, Merrill-Skoloff G, Barrett NE, Pixton KL, Weiler H, Cooley B, Newman DK, Newman PJ, Furie BC, Furie B, Gibbins JM. Platelet PECAM-1 inhibits thrombus formation in vivo. Blood 2006; 107: 53541.
  • 10
    Matsumura PW, Wolff K, Petzelbauer P. Endothelial cell tube formation depends on cadherin and CD31 interactions with filamentous actin. J Immunol 1997; 158: 340816.
  • 11
    Breier G, Breviario F, Caveda L, Berthier R, Schnürch H, Gotsch U, Vestweber D, Risau W, Dejana E. Molecular cloning and expression of murine vascular endothelial cadherin in early stage development of the cardiovascular system. Blood 1996; 87: 63041.
  • 12
    Tanaka Y, Albelda SM, Horgan KJ, van Seventer GA, Shimizu Y, Newman W, Hallam J, Newman PJ, Buck CA, Shaw S. CD31 expressed on distinctive T cell subsets is a preferential amplifier of β1 integrin-mediated adhesion. J Exp Med 1992; 176: 24553.
  • 13
    Piali L, Albelda SM, Baldwin HS, Hammel P, Gisler RH, Imhof BA. Murine platelet endothelial cell adhesion molecule (PECAM-1/CD31) modulates β2 integrins on lymphokine-activated killer cells. Eur J Immunol 1993; 23: 246471.
  • 14
    Newton-Nash DK, Newman PJ. A new role for platelet–endothelial cell adhesion molecule-1 (CD31): inhibition of TCR-mediated signal transduction. J Immunol 1999; 163: 6828.
  • 15
    Newman DK, Hamilton CA, Armstrong MJ, Newman PJ. Inhibition of antigen-receptor signaling by platelet endothelial cell-adhesion molecule-1 (CD31) requires an intact ITIM, SHP-2, and p56Lck. Blood 2000; 97: 23517.
  • 16
    Muller WA, Weigl SA, Deng X, Phillips DM. PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 1993; 178: 44960.
  • 17
    Duncan GS, Andrew DP, Takimoto H, Kaufman SA, Yoshida H, Spelberg J, Luis de La Pompa J, Elia A, Wakeham A, Karan-Tamir B, Muller WA, Senaldi G, Zukowski MM, Mak TW. Genetic evidence for functional redundancy of platelet endothelial-cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1 independent functions. J Immunol 1999; 162: 302230.
  • 18
    Woodfin A, Reichel C, Khandoga A, Corada M, Voisin M-B, Scheiermann C, Haskard DO, Dejana E, Krombach F, Nourshargh S. JAM-A mediates neutrophil transmigration in a stimulus-specific manner in vivo: evidence for sequential roles for JAM-A and PECAM-1 in neutrophil transmigration. Blood 2007; 110: 184856.
  • 19
    Huang MT, Larbi KY, Scheiermann C, Woodfin A, Gerwin N, Haskard DO, Nourshargh S. ICAM-2 mediates neutrophil transmigration in vivo: evidence for stimulus specificity and a role in PECAM-1-independent transmigration. Blood 2006; 107: 47217.
  • 20
    Solowiej A, Biswas P, Graesser D, Madri JA. Lack of platelet endothelial cell adhesion molecule-1 attenuates foreign body inflammation because of decreased angiogenesis. Am J Pathol 2003; 162: 95362.
  • 21
    Goel R, Schrank BR, Arora S, Boylan B, Fleming B, Miura H, Newman PJ, Molthen RC, Newman DK. Site-specific effects of PECAM-1 on atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 2008; 28: 19962002.
  • 22
    Harry BL, Sanders JM, Feaver RE, Lansey M, Deem TL, Zarbock A, Bruce AC, Pryor AW, Gelfand BD, Blackman BR, Schwartz MA, Ley K. Endothelial cell PECAM-1 promotes atherosclerotic lesions in areas of disturbed flow in ApoE-deficient-mice. Arterioscler Thromb Vasc Biol 2008; 28: 20038.
  • 23
    Jackson DE, Ward CM, Wang R, Newman PJ. The protein-tyrosine phosphatase SHP-2 binds PECAM-1 and forms a distinct signaling complex during platelet aggregation: evidence for a mechanistic link between PECAM-1 and integrin-mediated cellular signaling. J Biol Chem 1997; 272: 698693.
  • 24
    Edmead CE, Crosby DA, Southcott M, Poole AW. Thrombin-induced association of SHP-2 with multiple tyrosine-phosphorylated proteins in human platelets. FEBS Lett 1999; 459: 2732.
  • 25
    Newman PJ. Switched at birth: a new family for PECAM-1. J Clin Invest 1999; 103: 59.
  • 26
    Newman PJ, Newman DK. Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology. Arterioscler Thromb Vasc Biol 2003; 23: 95364.
  • 27
    Ilan N, Madri JA. PECAM-1: old friend, new partners. Curr Opin Cell Biol 2003; 15: 51524.
  • 28
    Sagawa K, Kimura T, Swieter M, Siraganian RP. The protein-tyrosine phosphatase SHP-2 associates with tyrosine-phosphorylated adhesion molecule PECAM-1 (CD31). J Biol Chem 1997; 272: 3108691.
  • 29
    Jackson DE, Kupcho KR, Newman PJ. Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of platelet endothelial cell-adhesion molecule-1 (PECAM-1) that are required for the cellular association and activation of the protein-tyrosine phosphatase, SHP-2. J Biol Chem 1997; 272: 2486875.
  • 30
    Feng GS, Hui CC, Pawson T. SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases. Science 1993; 259: 160711.
  • 31
    Freeman RM, Plutzky J Jr, Neel BG. Identification of a human src homology 2-containing protein-tyrosine-phosphatase: a putative homolog of Drosophila corkscrew. Proc Natl Acad Sci USA 1992; 89: 1123943.
  • 32
    Vogel W, Lammers R, Huang J, Ullrich A. Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation. Science 1993; 259: 161114.
  • 33
    Kui QC. The SHP-2 tyrosine phosphatase: signalling mechanisms and biological functions. Cell Res 2000; 10: 27988.
  • 34
    Fukunaga K, Noguchi T, Takeda H, Matozaki T, Hayashi Y, Itoh H, Kasuga M. Requirement for protein-tyrosine phosphatase SHP-2 in insulin-induced activation of c-jun NH2-terminal kinase. J Biol Chem 2000; 275: 520813.
  • 35
    Huyer G, Alexander DR. Immune signalling: SHP-2 docks at multiple ports. Curr Biol 1999; 9: 12932.
  • 36
    Liu Y, Rohrschneider LR. The gift of Gab. FEBS Lett 2002; 515: 17.
  • 37
    Koyama T, Nakaoka Y, Fujio Y, Hirota H, Nishida K, Sugiyama S, Okamoto K, Yamauchi-Takihara K, Yoshimura M, Mochizuki S, Hori M, Hirano T, Mochizuki N. Interaction of scaffolding adaptor proteín Gab1 with tyrosine phosphatase SHP-2 negatively regulates IGF-I-dependent myogenic differentiation via ERK1/2 signalling pathway. J Biol Chem 2008; 35: 2423444.
  • 38
    Zhang SQ, Tsiaras WG, Araki T, Wen G, Minichiello L, Klein R, Neel BG. Receptor-specific regulation of phosphatidylinositol 3′-kinase activation by the protein tyrosine phosphatase SHP-2. Mol Cell Biol 2002; 22: 406272.
  • 39
    Gibbins JM, Briddon S, Shutes A, van Vugt MJ, van de Winkel JG, Saito T, Watson SP. The p85 subunit of phosphatidylinositol 3-kinase associates with the Fc receptor gamma-chain and linker for activation of T cells (LAT) in platelets stimulated by collagen and convulxin. J Biol Chem 1998; 273: 3443743.
  • 40
    Watson SP, Asazuma N, Atkinson B, Berlanga O, Best D, Bobe R, Jarvis G, Marshall S, Snell D, Stafford M, Tulasne D, Wilde J, Wonerow P, Frampton J. The role of ITAM-and ITIM-coupled receptors in platelet activation by collagen. Thromb Haemost 2001; 86: 27688.
  • 41
    Gibbins JM. Platelet adhesion signaling and the regulation of thrombus formation. J Cell Sci 2004; 117: 341525.
  • 42
    Jones S, Tucker KL, Saga T, Kaiser WJ, Barrett NE, Lowry PJ, Zimmer A, Hunt SP, Emerson M, Gibbins JM. Peripheral tachykinins and neurokinin receptor NK1 are required for platelet thrombus formation. Blood 2008; 111: 60512.
  • 43
    Tucker KL, Sage T, Stevens JM, Jordan PA, Jones S, Barrett NE, St-Arnaud R, Frampton J, Dedhar S, Gibbins JM. A dual role for integrin linked kinase in platelets: regulating integrin function and alpha-granule secretion. Blood 2008; 112: 452331.
  • 44
    Asselin J, Gibbins JM, Achison M, Lee YH, Morton LF, Farndale RW, Barnes MJ, Watson SP. A collagen-like peptide stimulates tyrosine phosphorylation of SyK and phospholipase Cγ2 in platelets independent of the integrin alpha2beta1. Blood 1997; 89: 123542.
  • 45
    Jones CI, Garner SF, Moraes LA, Kaiser WJ, Rankin A, Ouwehand WH, Goodall AH, Gibbins JM. PECAM-1 expression and activity negatively regulate multiple platelet signaling pathways. FEBS Lett 2009; 583: 361824.
  • 46
    Watanabe N, Nakajima H, Suzuki H, Oda A, Matsubara Y, Moroi M, Terauchi Y, Kadowaki T, Suzuki H, Koyasu S, Ikeda Y, Handa M. Functional phenotype of phosphoinositide 3-kinase p85α-null platelets characterized by an impaired response to GPVI stimulation. Blood 2003; 102: 5418.
  • 47
    Cunnick JM, Mei L, Doupnik CA, Wu J. Phosphotyrosines 627 and 659 of Gab1 constitute a bisphosphoryl tyrosine-based activation motif (BTAM) conferring binding and activation of SHP-2. J Biol Chem 2001; 276: 243807.
  • 48
    Kojima H, Shinagawa A, Shimizu S, Kanada H, Hibi M, Hirano T, Nagasawa T. Role of phosphatidylinositol-3 kinase and its association with Gab1 in thrombopoietin-mediated up-regulation of platelet function. Exp Hematol 2001; 29: 61622.
  • 49
    Lee FA, Van Lier M, Relou IA, Foley L, Akkerman JW, Heijnem HF, Farndale RW. Lipid rafts facilitate the interaction of PECAM-1 with the glycoprotein VI–FcR gamma-chain complex in human platelets. J Biol Chem 2006; 281: 393308.
  • 50
    Newland SA, Macaulay IC, Floto RA, de Vet EC, Ouwehand WH, Watkins NA, Lyons PA, Campbell RD. The novel inhibitory receptor G6b-B, a novel immunoreceptor tyrosine-based inhibitory motif protein. Mol Cell Proteomics 2007; 6: 54864.
  • 51
    Canobbio I, Stefanini L, Cipolla L, Ciraolo E, Gruppi C, Balduini C, Hirsch E, Torti M. Genetic evidence for a predominant role of PI3K beta catalytic activity in ITAM- and integrin-mediated signaling in platelets. Blood 2009; 114: 21936.
  • 52
    Martin V, Guillermet-Guibert J, Chicanne G, Cabou C, Jandrot-Perrus M, Plantavid M, Vanhaesebroeck B, Payrastre B, Gratacap MP. Deletion of the p110β isoform of phosphoinositide 3-kinase in platelets reveals its central role in Akt activation and thrombus formation in vitro and in vivo. Blood 2010; 115: 200813.